$PGR

Niederst Lori A sold $1.5M of PGR

Niederst Lori A (Chief Personal Lines Officer) sold 7,339 shares of PROGRESSIVE CORP/OH/ (PGR) at $209.29 ($1.54M total) on 2026-08-13 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Niederst Lori A
Published Aug 17, 2026, 6:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 17, 2026, 7:03 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PGR
Neutral
high confidence
Mentioned
$PGR
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGRNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale size, price per share, and that it was executed under a pre-arranged 10b5-1 plan; no other company-specific developments are provided.

02

Market read

Traders may note the insider sale for sentiment, but the filing lacks fundamental catalysts and is likely to have limited impact on valuation.

03

What to watch

The brief does not include any buy-side insider activity, changes in total holdings beyond the post-transaction figure, or any company-specific catalyst, so the signal-to-noise is low.

Relevance 5/10Novelty 3/10Timing: filed 2026-08-17, transaction dated 2026-08-13

Background

The article is a SEC Form 4 insider transaction disclosure for Progressive (PGR) by Lori A. Niederst, Chief Personal Lines Officer.

Company-level read

Ticker impact

$PGRNeutralHigh confidence
Context

Progressive’s Chief Personal Lines Officer filed a Form 4 open-market sale of 7,339 shares for about $1.54M under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.

Evidence & confidence

The filing is a routine Form 4 transaction with a pre-arranged 10b5-1 plan and no accompanying guidance, operational change, or regulatory/legal event described.

Market effects

Minimal; insider selling at one insurer does not imply sector-wide underwriting or capital changes in the text.

None indicated.

None indicated.

Counterpoint

Because the sale is under a pre-arranged 10b5-1 plan, it may reflect liquidity planning rather than bearish expectations, limiting interpretive value.

Key entities

  • Progressive Corp

    Subject of the Form 4 insider transaction disclosure.

  • Lori A. Niederst

    Chief Personal Lines Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGRHighAI 8/10

Progressive (PGR) Reports Q3 Earnings Beat, Revenue Misses Expectations

Progressive (PGR) reported Q3 earnings of $4.6 per share, beating estimates by 3.14%, but revenue of $23.36 billion missed expectations by 0.22%. The company has exceeded EPS estimates for four consecutive quarters. Shares are down 2.1% YTD. The next quarter's EPS estimate is $4.02 with revenue expected at $23.15 billion. The insurance sector is currently in the top 26% of Zacks industries. United Fire Group (UFCS) is expected to report a 20.7% YOY earnings decline.

$PGRHigh

Wells Fargo cuts Progressive stock price target on growth concerns

Wells Fargo reduced its price target on Progressive Corp. (PGR) to $196 from $201, citing policy losses and higher accident year loss ratios. The firm lowered its 2027 earnings estimate by 2.4%, remaining 13.1% below consensus. Progressive trades at a P/E ratio of 10.69 and is set to report earnings on October 14. Other analysts have mixed ratings and price targets, with some expecting outperformance.

$PGRMedAI 8/10

Progressive earnings analysis: questions answered and next catalysts

Progressive Corp (PGR) reported Q3 FY2026 earnings with EPS of $4.37, missing estimates by 1.13%, and revenue of $22.30B, missing expectations by $200M. The stock fell 6.35%. Growth slowed, but underwriting remains strong. Analysts expect EPS to peak in FY2026 and decline thereafter, with revenue still forecast to rise. Key catalysts include Q4 results, monthly performance, catastrophe losses, and estimate revisions.